Table 1.

Patient characteristics by HIV status

DemographicsHIV+ (n=510)HIVGeneral Unmatched (n=94,948)P ValueHIV+ Matched Patients (n=467)HIV- Matched Controls (n=4,670)P Value
Follow-up time in years, median (IQR)3.8 (2.4–5.5)4.7 (3.0–6.9)<0.0013.8 (2.5–5.5)4.1 (2.6–5.8)0.02
Recipient characteristics (%)
 Age≥50 yr38.658.8<0.00138.838.8>0.99
 Male79.661.0<0.00179.261.8<0.001
 African American race71.026.5<0.00170.970.9>0.99
 BMI (kg/m2)
  <18.51.92.4<0.0012.12.5<0.001
  18.5–24.947.230.447.529.4
  25–29.932.833.933.232.1
   ≥3018.133.317.336.0
 Cause of renal failure
  Diabetes10.425.4<0.00111.121.8<0.001
  Drug-related nephrotoxicity1.01.31.11.1
  FSGS4.56.44.99.1
  Glomerulonephritis1.05.21.14.7
  Hypertension32.423.132.132.6
  IgA nephropathy1.64.61.12.6
  Polycystic kidney disease2.29.82.45.3
  Systemic lupus0.43.00.44.8
  Other46.521.245.818.0
 Peak PRA>80%6.36.20.95.15.1>0.99
 HCV infection24.25.5<0.00122.522.5>0.99
 Antithymocyte globulin induction27.842.6<0.00128.944.6<0.001
 CNI maintenance regimen89.692.30.0190.690.6>0.99
 Maintenance steroids75.166.1<0.00176.967.0<0.001
 Acute rejection within 1 yr17.88.8<0.00117.110.6<0.001
Donor characteristics (%)
 Age≥50 yr23.328.80.0123.125.10.34
 Race
African American24.114.00.2524.826.50.44
Caucasian60.268.959.559.9
Other15.717.015.613.6
 Living donor27.738.4<0.00129.129.1>0.99
 Expanded criteria donor8.811.70.048.610.50.18
 Donor after cardiac death7.57.00.707.18.40.31
 CIT>10 h (among deceased donors)80.680.40.9480.280.2>0.99